Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMD3100 plus G-CSF versus placebo plus G-CSF for stem cell mobilization in multiple myeloma
2005-003599-39Phase 3Completed
- Sponsor
- AnorMED Inc.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple myeloma (MM) comparing plerixafor + filgrastim with placebo + filgrastim (2 arms). Primary endpoint: Primary efficacy endpoint. Started Sep 2005; status: completed.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-003599-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003599-39.